Trevor Johnson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Trevor Johnson

Showing results (21-30 of 25) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 25 results.

Bioorganic & Medicinal Chemistry Letters|December 13, 2005

SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitorsNicola M Heron, Malcolm Anderson, David P Blowers, et al.

Heart Rhythm|July 25, 2024

Appropriate and inappropriate ICD shocks in patients with LVADs: Prevalence, associated factors, and etiologiesAndrew Andreae, Eric Black-Maier, Kelly Arps, et al.

Journal of Medicinal Chemistry|February 3, 2006

Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitorsFrédéric H Jung, Georges Pasquet, Christine Lambert-van der Brempt, et al.

Nature Communications|April 15, 2020

Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.

Journal of Medicinal Chemistry|March 22, 2007

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.

Pageof 3

Search research articles

Showing results (21-30 of 25) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 25 results.

Bioorganic & Medicinal Chemistry Letters|December 13, 2005

SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitorsNicola M Heron, Malcolm Anderson, David P Blowers, et al.

Heart Rhythm|July 25, 2024

Appropriate and inappropriate ICD shocks in patients with LVADs: Prevalence, associated factors, and etiologiesAndrew Andreae, Eric Black-Maier, Kelly Arps, et al.

Journal of Medicinal Chemistry|February 3, 2006

Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitorsFrédéric H Jung, Georges Pasquet, Christine Lambert-van der Brempt, et al.

Nature Communications|April 15, 2020

Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.

Journal of Medicinal Chemistry|March 22, 2007

Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.

Pageof 3